Skip to main content
Emulating trials and quantifying bias: The convergence of health technology assessment agency real-world evidence guidance
Read on Value in Health
Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
Read on ScienceDirect
Access in all areas? A round up of developments in market access and health technology assessment
Read Part 3
Read Part 4
EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?
Read on Becaris
First in class, best in class or a wild card: who will dominate the anti-obesity medication market?
Read on Becaris
Why is target trial emulation not being used in health technology assessment real-world data submissions?
Read on Becaris
Tackling health inequalities through the development of the wider public health workforce
Read on PubMed
RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
Part 15
Part 16
A review of 25 years of National Institute of Health and Care Excellence decision making
Read on Becaris